183 related articles for article (PubMed ID: 28717741)
1. Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs.
Singh S; Granberg D; Wolin E; Warner R; Sissons M; Kolarova T; Goldstein G; Pavel M; Öberg K; Leyden J
J Glob Oncol; 2017 Feb; 3(1):43-53. PubMed ID: 28717741
[TBL] [Abstract][Full Text] [Related]
2. Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results From a Large Patient Survey in the United States.
Wolin EM; Leyden J; Goldstein G; Kolarova T; Hollander R; Warner RRP
Pancreas; 2017; 46(5):639-647. PubMed ID: 28328615
[TBL] [Abstract][Full Text] [Related]
3. Patient-reported experience of the impact and burden of neuroendocrine tumors: Oceania patient results from a large global survey.
Leyden J; Pavlakis N; Chan D; Michael M; Clarke S; Khasraw M; Price T
Asia Pac J Clin Oncol; 2018 Jun; 14(3):256-263. PubMed ID: 29105989
[TBL] [Abstract][Full Text] [Related]
4. Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Leyden S; Kolarova T; Bouvier C; Caplin M; Conroy S; Davies P; Dureja S; Falconi M; Ferolla P; Fisher G; Goldstein G; Hicks RJ; Lawrence B; Majima Y; Metz DC; O'Toole D; Ruszniewski P; Wiedenmann B; Hollander R;
Int J Cancer; 2020 Mar; 146(5):1316-1323. PubMed ID: 31509608
[TBL] [Abstract][Full Text] [Related]
5. Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention.
Guccione L; Gough K; Drosdowsky A; Fisher K; Price T; Pavlakis N; Khasraw M; Wyld D; Ransom D; Kong G; Rogers M; Leyden S; Leyden J; Michael M; Schofield P
JMIR Res Protoc; 2019 Dec; 8(12):e14361. PubMed ID: 31793892
[TBL] [Abstract][Full Text] [Related]
6. Patient reported experience of the burden of neuroendocrine tumors and impact of eSHINE Patient Support Program on patient quality of life.
Wakelin K
Asia Pac J Clin Oncol; 2020 Nov; 16 Suppl 7():3-8. PubMed ID: 33145888
[TBL] [Abstract][Full Text] [Related]
7. Patient Survey of the Physical, Emotional, and Informational Challenges for Patients Living with Neuroendocrine Tumors.
Khan MS; Mellar K; Watts R; Bocher-Pianka I; Majdi A; Goldstein G
Oncol Ther; 2020 Jun; 8(1):67-80. PubMed ID: 32700067
[TBL] [Abstract][Full Text] [Related]
8. The unmet supportive care needs, quality of life, and care experiences of patients with functioning and non-functioning Neuroendocrine tumours (NETs) at early diagnosis.
Guccione L; Gough K; Drosdowsky A; Price T; Pavlakis N; Wyld D; Ransom D; Michael M; Schofield P
Patient Educ Couns; 2022 Jan; 105(1):212-220. PubMed ID: 34030927
[TBL] [Abstract][Full Text] [Related]
9. Patient experiences of having a neuroendocrine tumour: a qualitative study.
Feinberg Y; Law C; Singh S; Wright FC
Eur J Oncol Nurs; 2013 Oct; 17(5):541-5. PubMed ID: 23522828
[TBL] [Abstract][Full Text] [Related]
10. The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumors.
Ploeckinger U; Kloeppel G; Wiedenmann B; Lohmann R;
Neuroendocrinology; 2009; 90(4):349-63. PubMed ID: 19776553
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, Germany.
Hörsch D; Schmid KW; Anlauf M; Darwiche K; Denecke T; Baum RP; Spitzweg C; Grohé C; Presselt N; Stremmel C; Heigener DF; Serke M; Kegel T; Pavel M; Waller CF; Deppermann KM; Arnold R; Huber RM; Weber MM; Hoffmann H
Oncol Res Treat; 2014; 37(5):266-76. PubMed ID: 24853787
[TBL] [Abstract][Full Text] [Related]
12. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
13. Comparison of health-related quality of life in patients with neuroendocrine tumors with quality of life in the general US population.
Beaumont JL; Cella D; Phan AT; Choi S; Liu Z; Yao JC
Pancreas; 2012 Apr; 41(3):461-6. PubMed ID: 22422138
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and Satisfaction of Using NET VITALS Self-assessment Tool Among Patients With Neuroendocrine Tumors.
Li D; Imbesi GJ; Yen L; Kim H; Sun CL; Crook CJ; Ballena R; Zhang YH; Allen R; Sedrak M; Singh G
Pancreas; 2022 Apr; 51(4):319-324. PubMed ID: 35775639
[TBL] [Abstract][Full Text] [Related]
15. Supporting Medical Home Transformation Through Evaluation of Patient Experience in a Large Culturally Diverse Primary Care Safety Net.
Cook N; Hollar TL; Zunker C; Peterson M; Phillips T; De Lucca M
J Public Health Manag Pract; 2016; 22(3):265-74. PubMed ID: 25867494
[TBL] [Abstract][Full Text] [Related]
16. Comparing ownership and use of bed nets at two sites with differential malaria transmission in western Kenya.
Ernst KC; Hayden MH; Olsen H; Cavanaugh JL; Ruberto I; Agawo M; Munga S
Malar J; 2016 Apr; 15():217. PubMed ID: 27079380
[TBL] [Abstract][Full Text] [Related]
17. Nutrition and neuroendocrine tumors: An update of the literature.
Altieri B; Barrea L; Modica R; Muscogiuri G; Savastano S; Colao A; Faggiano A
Rev Endocr Metab Disord; 2018 Jun; 19(2):159-167. PubMed ID: 30267297
[TBL] [Abstract][Full Text] [Related]
18. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
20. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus).
Phan AT; Oberg K; Choi J; Harrison LH; Hassan MM; Strosberg JR; Krenning EP; Kocha W; Woltering EA; Maples WJ;
Pancreas; 2010 Aug; 39(6):784-98. PubMed ID: 20664476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
